Affimed NV (NASDAQ:AFMD)

2.15
Delayed Data
As of Oct 04
 +0.01 / +0.47%
Today’s Change
1.93
Today|||52-Week Range
7.35
-61.05%
Year-to-Date
No recent news for Affimed NV.

Today’s Trading

Previous close2.14
Today’s open2.19
Day’s range2.12 - 2.24
Volume34,090
Average volume (3 months)1,069,068
Market cap$300.6M
Data as of 4:00pm ET, 10/04/2022

Growth & Valuation

Earnings growth (last year)-0.71%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+47.58%
P/E ratioNM
Price/Sales13.83
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
OCULOcular Therapeutix I...+0.33+8.08%
CNCEConcert Pharmaceutic...+0.11+1.67%
STROSutro Biopharma Inc+0.09+1.55%
AVDLAvadel Pharmaceutica...+0.88+17.53%
Data as of 4:00pm ET, 10/04/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$47.7M
Annual profit (last year)-$68.0M
Net profit margin-142.50%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Heidelberg, Baden Wuerttemberg

Forecasts